<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Inside Vaccines &#187; vaccine recommendations</title>
	<atom:link href="http://insidevaccines.com/wordpress/tag/vaccine-recommendations/feed/" rel="self" type="application/rss+xml" />
	<link>http://insidevaccines.com/wordpress</link>
	<description>A Forum for Parents from Parents</description>
	<lastBuildDate>Mon, 26 Jul 2010 06:58:07 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0</generator>
		<item>
		<title>Merck staph vaccine enters phase II</title>
		<link>http://insidevaccines.com/wordpress/2008/09/21/merck-staph-vaccine-enters-phase-ii/</link>
		<comments>http://insidevaccines.com/wordpress/2008/09/21/merck-staph-vaccine-enters-phase-ii/#comments</comments>
		<pubDate>Sun, 21 Sep 2008 18:01:51 +0000</pubDate>
		<dc:creator>generic</dc:creator>
				<category><![CDATA[General]]></category>
		<category><![CDATA[CDC; pros & cons]]></category>
		<category><![CDATA[efficacy]]></category>
		<category><![CDATA[immunization]]></category>
		<category><![CDATA[Impfaufklärung]]></category>
		<category><![CDATA[Impfberatung]]></category>
		<category><![CDATA[Kinderkrankheiten]]></category>
		<category><![CDATA[Krippentod]]></category>
		<category><![CDATA[protection]]></category>
		<category><![CDATA[Risikofaktoren]]></category>
		<category><![CDATA[risk factors]]></category>
		<category><![CDATA[Säuglingstod]]></category>
		<category><![CDATA[Schutz]]></category>
		<category><![CDATA[SIDS; STIKO; Kindstod]]></category>
		<category><![CDATA[vaccination]]></category>
		<category><![CDATA[vaccine]]></category>
		<category><![CDATA[vaccine mandates]]></category>
		<category><![CDATA[vaccine recommendations]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[Wirksamkeit]]></category>

		<guid isPermaLink="false">http://insidevaccines.com/wordpress/?p=206</guid>
		<description><![CDATA[From Forbes: VIENNA, Aug 28 (Reuters) &#8211; Austrian biotech firm Intercell &#60;ICEL.VI&#62; said on Thursday its partner Merck &#38; Co &#60;MRK.N&#62; has started a Phase II clinical trial to evaluate a vaccine candidate against Staphylococcus aureus infections. Merck is responsible for clinical development, manufacturing and marketing of the vaccine. Intercell is eligible to receive milestone [...]]]></description>
		<wfw:commentRss>http://insidevaccines.com/wordpress/2008/09/21/merck-staph-vaccine-enters-phase-ii/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
